Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MenC antibody persistence after pneumococcal vaccination
NCT00316654Phase 4Completed
- Sponsor
- Novartis
- Start
- Feb 2005
- Primary completion
- Oct 2005
- Countries
- 2
01
Overview
A Phase 4 trial of Meningococcal group C polysaccharide conjugate vaccine in meningococcal infection, sponsored by Novartis. Started Feb 2005; status: completed.
02
Drugs
Meningococcal group C polysaccharide conjugate vaccine
03
Conditions
meningococcal infection
Beyond the preview
Go deeper on NCT00316654.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00316654.